LTC1620113I2 - Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui - Google Patents

Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui

Info

Publication number: LTC1620113I2
Authority: LT; Lithuania
Prior art keywords: treatment; topical composition; dermatological diseases; ivermectin; ivermectin topical
Prior art date: 2003-04-24

Application number

LTPA2015033C

Other languages

English (en)

Original Assignee

Galderma S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-24

Filing date

2015-09-24

Publication date

2018-02-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33312271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LTC1620113(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-04-24 Priority claimed from FR0305048A external-priority patent/FR2854074B1/fr

2015-09-24 Application filed by Galderma S.A. filed Critical Galderma S.A.

2018-02-26 Publication of LTC1620113I2 publication Critical patent/LTC1620113I2/lt

Links

AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 title 1
SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 title 1
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
229960002418 ivermectin Drugs 0.000 title 1
230000000699 topical effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Dermatology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Dispersion Chemistry (AREA)
Molecular Biology (AREA)
Toxicology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)

LTPA2015033C 2003-04-24 2015-09-24 Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui LTC1620113I2 (lt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0305048A FR2854074B1 (fr)	2003-04-24	2003-04-24	Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
US46899403P	2003-05-09	2003-05-09
PCT/EP2004/004950 WO2004093886A1 (en)	2003-04-24	2004-04-22	Topical formulation of ivermectin for the treatment of dermatological conditions

Publications (1)

Publication Number	Publication Date
LTC1620113I2 true LTC1620113I2 (lt)	2018-02-26

Family

ID=33312271

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTPA2015033C LTC1620113I2 (lt)	2003-04-24	2015-09-24	Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui

Country Status (16)

Country	Link
US (6)	US7550440B2 (lt)
EP (1)	EP1620113B1 (lt)
JP (2)	JP5711867B2 (lt)
KR (1)	KR101187231B1 (lt)
AU (1)	AU2004231323C1 (lt)
BR (1)	BRPI0410503B8 (lt)
CA (1)	CA2522579C (lt)
CY (2)	CY1111797T1 (lt)
FR (1)	FR15C0069I2 (lt)
HU (1)	HUS1500048I1 (lt)
LT (1)	LTC1620113I2 (lt)
LU (1)	LU92915I2 (lt)
MX (1)	MXPA05011208A (lt)
PL (2)	PL378932A1 (lt)
RU (1)	RU2350333C3 (lt)
WO (1)	WO2004093886A1 (lt)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2004231323C1 (en) *	2003-04-24	2016-11-03	Galderma Holding SA	Topical formulation of ivermectin for the treatment of dermatological conditions
FR2854074B1 (fr)	2003-04-24	2007-11-23	Galderma Res & Dev	Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
WO2004103343A1 (fr) *	2003-05-25	2004-12-02	Yuwan Wang	Formulation a liberation prolongee a base de dimethicone
DE602005020912D1 (de)	2004-03-18	2010-06-10	Galderma Sa	Ivermectin enthaltende creme
FR2867684B1 (fr) *	2004-03-18	2006-05-05	Galderma Sa	Gel creme contenant de l'ivermectine
FR2883181B1 (fr) *	2005-03-17	2007-05-18	Galderma Sa	Composition a base d'une avermectine et d'acide azelaique notamment pour le traitement de la rosacee
FR2886851B1 (fr) *	2005-06-10	2007-10-05	Galderma Sa	Composition a base d'une avermectine et de metronidazole notamment pour le traitement de la rosacee
FR2886852B1 (fr) *	2005-06-10	2007-11-23	Galderma Sa	Composition a base d'une avermectine et d'hydrocortisone notamment pour le traitement de la rosacee
FR2886850B1 (fr) *	2005-06-10	2007-10-05	Galderma Sa	Composition a base d'une avermectine et de peroxyde de benzoyle notamment pour le traitement de la rosacee
FR2894823B1 (fr)	2005-12-20	2008-02-29	Galderma Sa	Composition de type emulsion inverse comprenant de l'ivermectine, et ses utilisations en cosmetique et en dermatologie
FR2900052B1 (fr) *	2006-04-19	2011-02-18	Galderma Sa	Composition comprenant au moins une phase aqueuse et au moins une phase grasse comprenant de l'ivermectine
FR2906468B1 (fr) *	2006-09-28	2012-09-21	Galderma Sa	Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques
FR2907012B1 (fr)	2006-10-12	2012-09-21	Galderma Sa	Composition dermatologique comprenant des nanocapsules d'avermectine, son procede de preparation et son utilisation
FR2907013B1 (fr) *	2006-10-12	2012-09-21	Galderma Sa	Produits de soin cutane a double compartiment comprenant de l'ivermectine, et leurs utilisations
ES2653259T3 (es)	2006-10-12	2018-02-06	Topaz Pharmaceuticals Inc.	Formulaciones tópicas de ivermectina y procedimientos de eliminación y profiláxis de piojos del cuerpo
US8901163B2 (en) *	2007-01-03	2014-12-02	Galderma S.A.	Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound
DE102007056424A1 (de) *	2007-11-23	2009-05-28	Neopharmacie Gmbh	Pharmazeutische Zusammensetzung, enthaltend eine Öl/Wasser-Emulsion
JP5694944B2 (ja)	2008-10-29	2015-04-01	トパズファーマシューティカルズインコーポレイティド	エマルション系局所治療用製剤の保存方式
CA2745457A1 (fr) *	2008-12-23	2010-07-01	Galderma S.A.	Composition pharmaceutique topique comprenant un principe actif sensible a l'eau
EP2748141B1 (en)	2011-08-24	2017-12-06	Novan, Inc.	Tunable nitric oxide-releasing macromolecules having multiple nitric oxide donor structures
US8642665B2 (en)	2011-12-16	2014-02-04	Conopco, Inc.	Environmentally friendly, low whitening compositions
JP5717034B2 (ja) *	2012-08-27	2015-05-13	丸和バイオケミカル株式会社	マクロライド系化合物を含有する土壌線虫防除用薬剤
FR3000397A1 (fr) *	2012-12-31	2014-07-04	Galderma Res & Dev	Combinaison de laropiprant et d'ivermectine pour le traitement de la rosacee
CN102872066B (zh)	2012-10-19	2014-07-02	厦门大学	伊维菌素及其衍生物的用途
FR3003761B1 (fr) *	2013-03-29	2016-01-01	Galderma Sa	Utilisation d'une lactone macrocyclique pour le traitement d'une infection par un papillomavirus
US9233118B2 (en) *	2013-07-08	2016-01-12	Galderma S.A.	Treatment of papulopustular rosacea with ivermectin
US9782425B2 (en)	2013-07-08	2017-10-10	Galderma S.A.	Treatment of papulopustular rosacea with ivermectin
US11813284B2 (en)	2013-08-08	2023-11-14	Novan, Inc.	Topical compositions and methods of using the same
JP6448641B2 (ja) *	2013-11-29	2019-01-09	ガルデルマ・ソシエテ・アノニム	アトピー性皮膚炎の治療及び／又は予防のためのアベルメクチンファミリー又はミルベマイシンファミリーの化合物
CN104706584A (zh) *	2013-12-16	2015-06-17	天津迈迪瑞康生物医药科技有限公司	一种伊维菌素脂肪乳浓缩液、其制备方法及用途
US10322082B2 (en)	2014-07-11	2019-06-18	Novan, Inc.	Topical antiviral compositions and methods of using the same
WO2016022066A1 (en) *	2014-08-04	2016-02-11	Jerry Tan Eye Surgery Pte Ltd	Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
FR3026010B1 (fr) *	2014-09-18	2016-11-04	Galderma Sa	Compositions comprenant un compose de la famille des avermectines et de la doxycycline pour le traitement de la rosacee
WO2016096797A1 (en)	2014-12-15	2016-06-23	Galderma Sa	Compound of the avermectin family in combination with an other active compound for treating and/or preventing inflammatory dermatoses
WO2016096795A1 (en) *	2014-12-15	2016-06-23	Galderma Sa	Compound of the avermectin family for treating and/or preventing inflammatory dermatoses
EP3362045B1 (en)	2015-10-13	2019-10-09	Galderma S.A.	A process for preparing a composition comprising a high concentration of one or more avermectins
AU2016336824B2 (en) *	2015-10-13	2022-05-26	Galderma Holding SA	A process for preparing a stable emulsion comprising one or more avermectins
MX389811B (es)	2016-08-04	2025-03-20	Nestle Skin Health Sa	Composiciones y el uso de las mismas para el tratamiento o la prevención de la rosácea
US11160780B2 (en) *	2016-09-30	2021-11-02	Aurobindo Pharma Ltd.	Pharmaceutical composition of ivermectin and process for preparation thereof
WO2018083196A1 (en)	2016-11-03	2018-05-11	Nestlé Skin Health Sa	Compositions comprising a compound of the avermectin family for the treatment and/or prevention of hand eczema
EP3326614A1 (en)	2016-11-24	2018-05-30	Nestlé Skin Health SA	Composition comprising avermectin compounds without solvents and propenetrating agents of avermectin compounds
EP3326608A1 (en)	2016-11-24	2018-05-30	Nestlé Skin Health SA	Composition comprising avermectin compounds without solid fatty substances
EP3326609A1 (en)	2016-11-24	2018-05-30	Nestlé Skin Health SA	Composition comprising avermectin compounds without gelling agents
AU2018282905B2 (en) *	2017-06-12	2022-06-02	Lakewood Amedex, Inc	Bisphosphocin gel formulations and uses thereof
SI3723739T1 (sl)	2017-12-15	2024-08-30	Tarsus Pharmaceuticals, Inc.	Paraziticidni pripravki na osnovi izoksazolina in njihova uporaba za zdravljenje blefaritisa
WO2019241498A1 (en)	2018-06-15	2019-12-19	W. R. Grace & Co.-Conn	Defoamer active, manufacturing method thereof, and defoaming formuation
SG11202102783QA (en) *	2018-09-28	2021-04-29	Galderma Res & Dev	Pharmaceutical composition in the form of a water-in-oil emulsion (w/o) and its uses
US12502377B2 (en)	2019-04-04	2025-12-23	Tarsus Pharmaceuticals, Inc.	Method of eradicating ticks that attach to humans using lotilaner formulations
WO2020210784A1 (en)	2019-04-12	2020-10-15	Ecolab Usa Inc.	Antimicrobial multi-purpose cleaner and methods of making and using the same
US12161752B2 (en)	2019-08-20	2024-12-10	Vishwanath Padmanabhan	Compositions and methods for the treatment of anterior blepharitis and posterior blepharitis
CN115379824A (zh) *	2019-08-21	2022-11-22	生物制药股份有限公司	用于局部递送活性剂的溶剂递送系统
KR20220052474A (ko)	2020-10-21	2022-04-28	순천향대학교 산학협력단	주사증 진단을 위한 마이크로RNA-21-3p 및 이의 용도
KR102480430B1 (ko)	2020-10-21	2022-12-21	순천향대학교 산학협력단	주사증 진단을 위한 마이크로RNA-31-5p 및 이의 용도
US11291679B1 (en) *	2021-03-22	2022-04-05	Mountain Valley Md Inc.	Injectable, infusable, instillable ivermectin adjuvant for cancer therapies
EP4062907A1 (fr)	2021-03-23	2022-09-28	Substipharm	Formulation par voie orale d'ivermectine et utilisations

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5332577A (en)	1988-12-27	1994-07-26	Dermamed	Transdermal administration to humans and animals
GB9422306D0 (en) *	1994-11-04	1994-12-21	Sandoz Ltd	Organic compounds
US5952371A (en) *	1996-10-16	1999-09-14	Merck & Co., Inc.	Triterpene derivatives with immunosuppressant activity
RU2138268C1 (ru) *	1997-09-22	1999-09-27	Мосин Владимир Александрович	Средство, подавляющее пролиферацию и вызывающее гибель опухолевых клеток, при этом защищающее нормальные клетки
US5952372A (en) *	1998-09-17	1999-09-14	Mcdaniel; William Robert	Method for treating rosacea using oral or topical ivermectin
US6310968B1 (en) *	1998-11-24	2001-10-30	Picker International, Inc.	Source-assisted attenuation correction for emission computed tomography
EP1154755A4 (en) *	1999-01-25	2003-08-13	Optime Therapeutics Inc	Liposomes FORMULATIONS
US6133310A (en) *	1999-08-26	2000-10-17	Parks; L. Dean	Method of treatment of rosacea
US6720001B2 (en) *	1999-10-18	2004-04-13	Lipocine, Inc.	Emulsion compositions for polyfunctional active ingredients
US6319945B1 (en)	2000-06-29	2001-11-20	L. Dean Parks	Method of treatment of seborrheic dermatitis
US6399652B1 (en) *	2000-06-29	2002-06-04	L. Dean Parks	Method of treating acne vulgaris using avermectin compound
US6399651B1 (en) *	2000-06-29	2002-06-04	L. Dean Parks	Method of treating dermatoses using avermectin compound
US20030064940A1 (en) *	2001-10-02	2003-04-03	Parks L. Dean	Kit for treating acne vulgaris using avermectin compound
DE10063946A1 (de) *	2000-12-20	2002-07-04	Basf Ag	Verwendung von Lichtschutzmittelkombinationen, die als wesentlichen Bestandteil 2,2'-p-Phenylen-bis(3,1-benzoxazin-4-on) enthalten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
CA2473760C (en) *	2002-02-08	2008-11-04	Merck & Co., Inc.	Topical ivermectin composition
WO2003075656A2 (en) *	2002-03-04	2003-09-18	Divergence, Inc.	Nematicidal fatty acid and fatty acid ester related compounds
AU2004231323C1 (en) *	2003-04-24	2016-11-03	Galderma Holding SA	Topical formulation of ivermectin for the treatment of dermatological conditions
FR2867684B1 (fr)	2004-03-18	2006-05-05	Galderma Sa	Gel creme contenant de l'ivermectine
DE602005020912D1 (de)	2004-03-18	2010-06-10	Galderma Sa	Ivermectin enthaltende creme

2004
- 2004-04-22 AU AU2004231323A patent/AU2004231323C1/en active Active
- 2004-04-22 PL PL378932A patent/PL378932A1/pl not_active Application Discontinuation
- 2004-04-22 PL PL04728811T patent/PL1620113T3/pl unknown
- 2004-04-22 MX MXPA05011208A patent/MXPA05011208A/es active IP Right Grant
- 2004-04-22 KR KR1020057019402A patent/KR101187231B1/ko not_active Expired - Lifetime
- 2004-04-22 WO PCT/EP2004/004950 patent/WO2004093886A1/en not_active Ceased
- 2004-04-22 BR BRPI0410503A patent/BRPI0410503B8/pt not_active IP Right Cessation
- 2004-04-22 JP JP2006505405A patent/JP5711867B2/ja not_active Expired - Lifetime
- 2004-04-22 CA CA2522579A patent/CA2522579C/en not_active Expired - Fee Related
- 2004-04-22 RU RU2005136438A patent/RU2350333C3/ru active Protection Beyond IP Right Term
- 2004-04-22 EP EP04728811A patent/EP1620113B1/en not_active Expired - Lifetime
2005
- 2005-10-24 US US11/255,910 patent/US7550440B2/en not_active Expired - Lifetime
2009
- 2009-05-19 US US12/468,287 patent/US8080530B2/en not_active Expired - Lifetime
- 2009-06-12 US US12/483,604 patent/US8093219B2/en not_active Expired - Lifetime
2011
- 2011-09-07 CY CY20111100856T patent/CY1111797T1/el unknown
- 2011-12-02 US US13/310,633 patent/US8415311B2/en not_active Expired - Fee Related
2012
- 2012-03-22 JP JP2012065724A patent/JP5538461B2/ja not_active Expired - Lifetime
- 2012-06-21 US US13/529,971 patent/US8470788B2/en not_active Expired - Fee Related
2013
- 2013-03-27 US US13/851,816 patent/US8598129B2/en not_active Expired - Fee Related
2015
- 2015-09-22 HU HUS1500048C patent/HUS1500048I1/hu unknown
- 2015-09-24 LT LTPA2015033C patent/LTC1620113I2/lt unknown
- 2015-10-14 FR FR15C0069C patent/FR15C0069I2/fr active Active
- 2015-12-17 LU LU92915C patent/LU92915I2/xx unknown
2016
- 2016-09-09 CY CY2016031C patent/CY2016031I2/el unknown

Also Published As

Publication number	Publication date
JP5538461B2 (ja)	2014-07-02
RU2005136438A (ru)	2006-05-27
EP1620113A1 (en)	2006-02-01
EP1620113B1 (en)	2011-07-13
WO2004093886A1 (en)	2004-11-04
PL1620113T3 (pl)	2011-10-31
PL378932A1 (pl)	2006-06-12
BRPI0410503B1 (pt)	2018-07-10
AU2004231323B2 (en)	2009-12-10
BRPI0410503A (pt)	2006-06-20
US8080530B2 (en)	2011-12-20
CY1111797T1 (el)	2015-10-07
CY2016031I1 (el)	2017-03-15
KR101187231B1 (ko)	2012-10-02
KR20060004667A (ko)	2006-01-12
MXPA05011208A (es)	2005-12-14
US20130209381A1 (en)	2013-08-15
RU2350333C3 (ru)	2018-08-24
BRPI0410503B8 (pt)	2021-05-25
FR15C0069I2 (fr)	2016-04-22
CA2522579C (en)	2012-08-28
US20090227668A1 (en)	2009-09-10
LU92915I2 (fr)	2016-02-17
US20060100165A1 (en)	2006-05-11
US8470788B2 (en)	2013-06-25
AU2004231323A1 (en)	2004-11-04
US8415311B2 (en)	2013-04-09
US8093219B2 (en)	2012-01-10
US20090252797A1 (en)	2009-10-08
FR15C0069I1 (lt)	2015-12-04
US8598129B2 (en)	2013-12-03
JP2012126738A (ja)	2012-07-05
US20120258062A1 (en)	2012-10-11
JP2006524212A (ja)	2006-10-26
US7550440B2 (en)	2009-06-23
AU2004231323C1 (en)	2016-11-03
CY2016031I2 (el)	2017-03-15
RU2350333C2 (ru)	2009-03-27
HUS1500048I1 (hu)	2017-10-30
CA2522579A1 (en)	2004-11-04
US20120077766A1 (en)	2012-03-29
JP5711867B2 (ja)	2015-05-07

Publication	Publication Date	Title
LTC1620113I2 (lt)	2018-02-26	Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
DK1620113T3 (da)	2011-09-12	Topisk formulering af ivermectin til behandling af dermatologiske lidelser
NO20053077D0 (no)	2005-06-23	Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
LTPA2014019I1 (lt)	2014-05-26	Fenetanolamino dariniai, skirti kvėpavimo ligoms gydyti
ITMI20020756A0 (it)	2002-04-09	Composizioni farmaceutiche topiche per il trattamento delle dermatiti
PT1485127E (pt)	2011-09-07	Administração de agentes para o tratamento de inflamação
EP1727530A4 (en)	2009-10-21	TOPICAL FORMULATIONS FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS
IS8398A (is)	2006-04-05	Lyfjasamsetningar til að meðhöndla æxli
NL1027833A1 (nl)	2005-06-23	Verbindingen bruikbaar bij therapie.
IS7691A (is)	2005-02-09	Lyfjasamsetningar til að meðhöndla æxli
ATE448232T1 (de)	2009-11-15	Substituierte heterozyklen
DE60223576D1 (de)	2007-12-27	Hautbehandlungszusammensetzung
DE112004000860D2 (de)	2006-02-02	Gating-Verfahren, Gating-Gerät, sowie Therapieeinrichtung
IL175535A (en)	2016-03-31	Compositions for treatment of neurodegenerative diseases
NL1024677A1 (nl)	2004-05-06	Therapeutische prolinederivaten.
DK1553950T3 (da)	2007-10-15	Terapeutisk behandling
EP1698330A4 (en)	2012-08-15	EXTERNAL ANALGESIC ANTI-INFLAMMATORY PREPARATION
DK1503747T3 (da)	2006-11-27	Diclofenacbaseret sammensætning til topisk behandling af sygdomme
PL355298A1 (pl)	2004-02-09	Preparat dermatologiczny do leczenia uszkodzesigma skóry
DE112004001618D2 (de)	2006-05-11	Pharmazeutischer Wirkstoff gegen Tumorerkrankungen
DK1596879T3 (da)	2011-04-11	Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
IT1320192B1 (it)	2003-11-26	Composizione terapeutica per la cura della psoriasi.
ZA200610350B (en)	2008-12-31	Topical formulations for treating allergic diseases
IT1338456B1 (it)	2007-03-12	Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato
AU2003252187A1 (en)	2003-12-02	Topical composition for the treatment of inflammatory conditions of the skin